This educational supplement, sponsored by Terumo Interventional Systems, is intended for readers in Europe only.
Highlights:
- Ana Oliveira (Centro Hospitalar Universitário de São João, Porto, Portugal) discusses experiences of adopting The Holmium Platform at her centre
- Irene Bargellini (Pisa University Hospital, Pisa, Italy) outlines the intentions of the iHEPAR study
- Kees Punt (Julius Center UMC Utrecht, Utrecht, The Netherlands) discusses the CAIRO7 study and the potential impact should it produce positive results
- Lambros Tselikas and Thierry De Baere provide an overview of the upcoming HOLM-Brave study
